Literature DB >> 9927288

Effects of pro- and antioxidative compounds on renal production of erythropoietin.

I Neumcke1, B Schneider, J Fandrey, H Pagel.   

Abstract

The most important stimulus for the enhanced synthesis of erythropoietin (Epo) is a lowered O2 tension in the tissue. However, the mechanism by which an impaired O2 supply is transduced into appropriate Epo production is still not fully understood. Recently, studies in human hepatoma cells (line HepG2) indicate that reactive O2 species are involved in the signal transduction from the cellular O2 sensor to the Epo gene. To clarify the role of reactive O2 species in the regulation of Epo synthesis in the kidney, the principal Epo-producing organ in vivo, we investigated the influence of potent pro- and antioxidants on Epo production in isolated perfused rat kidneys. Under normoxic conditions, the iron chelator desferrioxamine and the antioxidant vitamin A increased renal Epo production, mimicking hypoxic induction. In contrast, supplementation of the perfusion medium of hypoxically perfused kidneys with the prooxidant compounds H2O2 or pyrogallol caused a significant reduction of Epo synthesis. The inhibition of Epo formation by reactive O2 species could be completely antagonized by desferrioxamine and the hydroxyl radical-(OH*)-scavenger tetramethylthiourea. Vitamin A also antagonized the H2O2-dependent inhibition of hypoxically induced Epo synthesis. Interestingly, the addition of the antioxidant vitamin A to hypoxically perfused kidneys also induced Epo production significantly. Our data strongly support the idea that reactive O2 species, especially H2O2, are part of the signaling chain of the cellular O2-sensing mechanism regulating the renal synthesis of Epo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927288     DOI: 10.1210/endo.140.2.6529

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms.

Authors:  Z Dong; M A Venkatachalam; J Wang; Y Patel; P Saikumar; G L Semenza; T Force; J Nishiyama
Journal:  J Biol Chem       Date:  2001-03-12       Impact factor: 5.157

Review 2.  The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  J Mol Med (Berl)       Date:  2013-09-21       Impact factor: 4.599

3.  The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Luciana Tanca; Maria Cristina Cherchi; Carlo Floris; Itaru Omoto; Antonio Barracca; Tomas Ganz
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

Review 4.  Repression of gene expression by oxidative stress.

Authors:  Y Morel; R Barouki
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

5.  A reducing environment stabilizes HIF-2alpha in SH-SY5Y cells under hypoxic conditions.

Authors:  Hu Chen; Honglian Shi
Journal:  FEBS Lett       Date:  2008-10-26       Impact factor: 4.124

6.  Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment.

Authors:  Shuhong Guo; Minoru Miyake; Ke Jian Liu; Honglian Shi
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

Review 7.  Hyperoxia: a review of the risks and benefits in adult cardiac surgery.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2012-12

8.  Predictors of chemotherapy-induced severe anemia in cancer patients receiving chemotherapy.

Authors:  Abolfazl Razzaghdoust; Bahram Mofid; Parvin Peyghambarlou
Journal:  Support Care Cancer       Date:  2019-04-16       Impact factor: 3.603

9.  The mitochondria-targeted antioxidants and remote kidney preconditioning ameliorate brain damage through kidney-to-brain cross-talk.

Authors:  Denis N Silachev; Nikolay K Isaev; Irina B Pevzner; Ljubava D Zorova; Elena V Stelmashook; Svetlana V Novikova; Egor Y Plotnikov; Vladimir P Skulachev; Dmitry B Zorov
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Management of anemia of inflammation in the elderly.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  Anemia       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.